Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
Saint Joseph, MI
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
St. John Macomb Hospital
mi
from
Warren, MI
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
St. John Macomb Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Avera Cancer Institute
mi
from
Sioux Falls, SD
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Preoperative Herceptin and Navelbine for Breast Cancer
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Preoperative Herceptin and Navelbine for Breast Cancer
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Preoperative Herceptin and Navelbine for Breast Cancer
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Preoperative Herceptin and Navelbine for Breast Cancer
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Preoperative Herceptin and Navelbine for Breast Cancer
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Center
mi
from
Boston, MA
Preoperative Herceptin and Navelbine for Breast Cancer
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Food Effect Study of D-0502 Tablet in Healthy Volunteers
A Phase I, Randomized, Open Label, Two-Sequence, Two-Period Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of D-0502 Tablet in Postmenopausal Female Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Covance Daytona Beach Clinical Research Unit
mi
from
Daytona Beach, FL
Food Effect Study of D-0502 Tablet in Healthy Volunteers
A Phase I, Randomized, Open Label, Two-Sequence, Two-Period Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of D-0502 Tablet in Postmenopausal Female Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Daytona Beach Clinical Research Unit
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Oklahoma University Cancer Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Phase II Study of Cardiac Safety and Tolerability of an Adjuvant Chemotherapy Plus Trastuzumab With Lapatinib in Patients With Resected HER2 + Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Cancer Research Consortium
mi
from
Rochester, MN
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Phase II Study of Cardiac Safety and Tolerability of an Adjuvant Chemotherapy Plus Trastuzumab With Lapatinib in Patients With Resected HER2 + Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Cancer Research Consortium
mi
from
Rochester, MN
Click here to add this to my saved trials
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Moores UCSD Cancer Center
mi
from
San Diego, CA
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Effect of Increased Light Exposure on Fatigue in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Moores UCSD Cancer Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Vitamin D Supplementation in Women With DCIS and/or LCIS
An Exploratory Pilot Study of Vitamin D Supplementation in Women With DCIS and/or LCIS
Status: Enrolling
Updated:  12/31/1969
Inova Schar Cancer Institute
mi
from
Fairfax, VA
Vitamin D Supplementation in Women With DCIS and/or LCIS
An Exploratory Pilot Study of Vitamin D Supplementation in Women With DCIS and/or LCIS
Status: Enrolling
Updated: 12/31/1969
Inova Schar Cancer Institute
mi
from
Fairfax, VA
Click here to add this to my saved trials
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  12/31/1969
Sentara Surgery Specialists and Dorothy G Hoefer Comprehensive Breast Center
mi
from
Newport News, VA
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 12/31/1969
Sentara Surgery Specialists and Dorothy G Hoefer Comprehensive Breast Center
mi
from
Newport News, VA
Click here to add this to my saved trials
Neoadjuvant GW572016 to Treat Breast Cancer
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated:  12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Neoadjuvant GW572016 to Treat Breast Cancer
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neoadjuvant GW572016 to Treat Breast Cancer
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Neoadjuvant GW572016 to Treat Breast Cancer
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Neoadjuvant GW572016 to Treat Breast Cancer
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated:  12/31/1969
Baylor Breast Center
mi
from
Houston, TX
Neoadjuvant GW572016 to Treat Breast Cancer
A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study
Status: Enrolling
Updated: 12/31/1969
Baylor Breast Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Sustainable Approach to Increasing Cancer Screening
A Sustainable Approach to Increasing Cancer Screening
Status: Enrolling
Updated:  12/31/1969
Greater Lawrence Family Health Center (GLFHC)
mi
from
Lawrence, MA
A Sustainable Approach to Increasing Cancer Screening
A Sustainable Approach to Increasing Cancer Screening
Status: Enrolling
Updated: 12/31/1969
Greater Lawrence Family Health Center (GLFHC)
mi
from
Lawrence, MA
Click here to add this to my saved trials
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
A Phase II Window of Opportunity Trial of Ipilimumab and Nivolumab in Metastatic Recurrent HER2- Inflammatory Breast Cancer (IBC) The Win Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
A Phase II Window of Opportunity Trial of Ipilimumab and Nivolumab in Metastatic Recurrent HER2- Inflammatory Breast Cancer (IBC) The Win Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
A Phase I Study of a HER-2/Neu Peptide Based Vaccine With GM-CSF as an Adjuvant in Patients With Advanced Stage HER-2/Neu Expressing Cancers
Status: Enrolling
Updated:  12/31/1969
University of Washington School of Medicine
mi
from
Seattle, WA
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
A Phase I Study of a HER-2/Neu Peptide Based Vaccine With GM-CSF as an Adjuvant in Patients With Advanced Stage HER-2/Neu Expressing Cancers
Status: Enrolling
Updated: 12/31/1969
University of Washington School of Medicine
mi
from
Seattle, WA
Click here to add this to my saved trials
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
A Phase 1/2 Study of Bcl-2 Antisense Oligonucleotide G3139 in Combination With Doxorubicin and Docetaxel in Metastatic and Locally Advanced Breast Cancer
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
A Phase 1/2 Study of Bcl-2 Antisense Oligonucleotide G3139 in Combination With Doxorubicin and Docetaxel in Metastatic and Locally Advanced Breast Cancer
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Alta Bates Herrick Hospital Comprehensive Cancer Center
mi
from
Berkeley, CA
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Alta Bates Herrick Hospital Comprehensive Cancer Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Stanford Cancer Center
mi
from
Stanford, CA
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer
A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Stanford Cancer Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
Status: Enrolling
Updated:  12/31/1969
NorthShore University HealthSystem
mi
from
Evanston, IL
Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer
Status: Enrolling
Updated: 12/31/1969
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Partial Breast Irradiation
Phase I/II Partial Breast Irradiation With Concurrent Chemotherapy
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Partial Breast Irradiation
Phase I/II Partial Breast Irradiation With Concurrent Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated:  2/6/2006
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated: 2/6/2006
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Genetic Counseling in African American Women
Genetic Counseling for Breast Cancer Susceptibility in African American Women
Status: Enrolling
Updated:  3/21/2007
Univ of Pennsylvania
mi
from
Philadelphia, PA
Genetic Counseling in African American Women
Genetic Counseling for Breast Cancer Susceptibility in African American Women
Status: Enrolling
Updated: 3/21/2007
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study
Status: Enrolling
Updated:  10/23/2007
Premiere Oncology
mi
from
Santa Monica, CA
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 10/23/2007
Premiere Oncology
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Status: Enrolling
Updated:  3/25/2008
UCLA Center for East-West Medicine
mi
from
Santa Monica, CA
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
Status: Enrolling
Updated: 3/25/2008
UCLA Center for East-West Medicine
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Screening Mammography, Including Cost Comparisons
Status: Enrolling
Updated:  3/27/2008
Huntington Memorial Hospital/Hill Breast Center
mi
from
Pasadena, CA
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Screening Mammography, Including Cost Comparisons
Status: Enrolling
Updated: 3/27/2008
Huntington Memorial Hospital/Hill Breast Center
mi
from
Pasadena, CA
Click here to add this to my saved trials
Peer Counseling for Weight Loss
Peer Counseling for Weight Loss in African American Breast Cancer Survivors
Status: Enrolling
Updated:  9/4/2008
Wayne State University
mi
from
Detroit, MI
Peer Counseling for Weight Loss
Peer Counseling for Weight Loss in African American Breast Cancer Survivors
Status: Enrolling
Updated: 9/4/2008
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Aromatase Inhibitor Clinical Trial
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated:  9/24/2008
Indiana University
mi
from
Indianapolis, IN
Aromatase Inhibitor Clinical Trial
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Aromatase Inhibitor Clinical Trial
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated:  9/24/2008
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins
mi
from
Baltimore, MD
Aromatase Inhibitor Clinical Trial
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Aromatase Inhibitor Clinical Trial
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated:  9/24/2008
UMCCC
mi
from
Ann Arbor, MI
Aromatase Inhibitor Clinical Trial
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Status: Enrolling
Updated: 9/24/2008
UMCCC
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Menopause and Meditation for Breast Cancer Survivors
Menopause and Meditation for Breast Cancer Survivors
Status: Enrolling
Updated:  10/13/2008
University of Pittsburgh
mi
from
Pittsburgh, PA
Menopause and Meditation for Breast Cancer Survivors
Menopause and Meditation for Breast Cancer Survivors
Status: Enrolling
Updated: 10/13/2008
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Autologous Fat Grafting to the Breast
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated:  11/17/2008
Houma Outpatient Surgery Center
mi
from
Metairie, LA
Autologous Fat Grafting to the Breast
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated: 11/17/2008
Houma Outpatient Surgery Center
mi
from
Metairie, LA
Click here to add this to my saved trials
Autologous Fat Grafting to the Breast
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated:  11/17/2008
Medical Center of Louisiana New Orleans, LSU Health Sciences Center
mi
from
New Orleans, LA
Autologous Fat Grafting to the Breast
Autologous Fat Grafting to the Breast
Status: Enrolling
Updated: 11/17/2008
Medical Center of Louisiana New Orleans, LSU Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women.
Status: Enrolling
Updated:  12/15/2008
New York Downtown Hospital
mi
from
New York, NY
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women.
Status: Enrolling
Updated: 12/15/2008
New York Downtown Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated:  1/20/2009
The Mayo Clinic
mi
from
Rochester, MN
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer in Women With Breast Cancer Receiving Radiation Therapy
Status: Enrolling
Updated: 1/20/2009
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
A Phase II Trial of Mammosite Breast Brachytherapy Optimization in the Treatment of Stage 0, I and II Breast Carcinoma
Status: Enrolling
Updated:  4/28/2009
Yale University School of Medicine
mi
from
New Haven, CT
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
A Phase II Trial of Mammosite Breast Brachytherapy Optimization in the Treatment of Stage 0, I and II Breast Carcinoma
Status: Enrolling
Updated: 4/28/2009
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
A Phase II Study of Rapamycin (Rapamune, Sirolimus) and Trastuzumab (Herceptin) for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  6/5/2009
Bridgeport Hospital
mi
from
Bridgeport, CT
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
A Phase II Study of Rapamycin (Rapamune, Sirolimus) and Trastuzumab (Herceptin) for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 6/5/2009
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials